Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis

Research output: Contribution to journalJournal articleResearchpeer-review

  1. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum

    Research output: Contribution to journalReviewResearchpeer-review

  1. The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Cholesteryl ester storage disease of clinical and genetic characterisation: A case report and review of literature

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. An update on cirrhotic cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  • PREDICT STUDY group of the EASL-CLIF CONSORTIUM
View graph of relations

INTRODUCTION: Acute decompensation (AD) of cirrhosis may present without acute-on-chronic liver failure (ACLF) (AD-No ACLF), or with ACLF phenotype (AD-ACLF) defined by organ failure(s). Precipitants may induce AD. This multicenter, prospective, observational PREDICT study (NCT03056612) analyzes and characterizes the precipitants leading to both of these AD phenotypes.

PATIENTS AND METHODS: The PREDICT study included 1273 non-electively hospitalized patients with AD (No-ACLF=1071; ACLF=202). Medical history, clinical and laboratory data were collected at enrolment and during 90-day follow up, with particular attention to the following characteristics of precipitants: induction of organ dysfunction or failure, systemic inflammation, chronology, intensity, and relationship to outcome.

RESULTS: Among various clinical events, four distinct events were precipitants consistently related to AD, including proven bacterial infections, severe alcoholic hepatitis, gastrointestinal (GI) bleeding with shock and toxic encephalopathy. Among patients with precipitants in the AD-No ACLF cohort and the AD-ACLF cohort (38% and 71%, respectively), almost all (96% and 97%, respectively) showed proven bacterial infection and severe alcoholic hepatitis, either alone or in combination with other events. In both AD phenotypes, patients with proven bacterial infections or severe alcoholic hepatitis had a similar survival. The number of precipitants was associated with significantly increased 90-day mortality, and was paralleled by increasing levels of surrogates for systemic inflammation. Importantly, adequate first-line antibiotic treatment of proven bacterial infections was associated with lower ACLF development rate and lower 90-day mortality.

CONCLUSIONS: This study identified precipitants that are significantly associated with a distinct clinical course and prognosis of patients with AD and specific preventive and therapeutic strategies targeting these events may improve outcome in decompensated cirrhosis.

Original languageEnglish
JournalJournal of Hepatology
ISSN0168-8278
DOIs
Publication statusE-pub ahead of print - 20 Nov 2020

ID: 61307619